Potential Health Effects of Heavy Metals in Cannabis Flower, Concentrates, Vape Devices, and Vape Emissions (2022)

Mike Van Dyke, PhD
Associate Professor, Center for Health, Work, and Environment, Colorado School of Public Health, University of Colorado Anschutz Medical Campus

Inhalation exposure to heavy metals such as lead, cadmium, arsenic, nickel, mercury, and manganese can increase the risk for cancer as well as neurological, renal, cardiovascular, and hepatic outcomes. Smoking or vaping cannabis products can result in inhalation exposure to many different heavy metals due to plant absorption of these metals from soil, irrigation water, or fertilizers and leaching of these metals from vape hardware. Currently, cannabis is regulated for only four heavy metals (lead, cadmium, arsenic, and mercury) despite known health effects from other co-occurring heavy metals. Pharmaceutical products are regulated for 24 heavy metal or “elemental” impurities. Metal exposure from cannabis vaping represents a problem with significant public health urgency, given that cannabis vaping as the primary method of use has increased 50% between 2017 and 2019 in the U.S., and that past research has identified chromium, lead, tin, and nickel as detectable in cannabis vapors at higher concentrations than in tobacco smoke. This project brings together an innovative partnership between academic researchers and Kaycha Laboratories, a national cannabis testing laboratory, to answer important public health questions including the levels of 21 heavy metals in commercially grown cannabis, vape device construction and use conditions important in leaching of these heavy metals into cannabis oils, and most importantly, the potential health risks from exposure to these heavy metals through smoking or vaping cannabis.

More FY23 Research

Edible Roulette or a Sure Bet? Evaluating Testing Standards and Consistency in Colorado’s Edible Products (2024)

Duncan Mackie, PhD,
Director of Pharmacology & Experimental Therapeutics, MedPharm Holdings

Cinnamon Bidwell, PhD,
Institute of Cognitive Science Faculty, Assistant Professor, University of Colorado Boulder

...

Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial (2022)

Kent Hutchison, PhD
Institute of Cognitive Science Affiliated Faculty & Professor, University of Colorado Boulder

Traumatic brain injury (TBI) represents a major public health burden due...

Potential Health Effects of Heavy Metals in Cannabis Flower, Concentrates, Vape Devices, and Vape Emissions (2022)

Mike Van Dyke, PhD
Associate Professor, Center for Health, Work, and Environment, Colorado School of Public Health, University of Colorado Anschutz Medical Campus

Inhalation exposure to...

Examining the adaptive roles of plant defensive chemistry on pest resistance in Cannabis sativa (2022)

Punya Nachappa, PhD
Associate Professor, Entomology, Department of Agricultural Biology, Colorado State University

Understanding how plants respond to insect herbivores can provide new insights into plant-insect...

Isolation and Pharmacological Evaluation of Phytocannabinoids for Alzheimer’s Disease (2022)

Duncan Mackie, PhD,
Director of Pharmacology & Experimental Therapeutics, MedPharm Holdings

Cinnamon Bidwell, PhD,
Institute of Cognitive Science Faculty, Assistant Professor, University of Colorado Boulder

...

Preventative and treatment effects of broad-spectrum cannabidiol (CBD) in a rat model of comorbid autism and epilepsy: A mechanistic study (2022)

Christopher Lowry, PhD
Associate Professor, Integrative Physiology, University of Colorado Boulder

Over 50% of children with autism spectrum disorder (ASD) show sub-clinical epileptic spikes by adolescence...